155 related articles for article (PubMed ID: 32905596)
41. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
[TBL] [Abstract][Full Text] [Related]
42. Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.
Herretes S; Ross DB; Duffort S; Barreras H; Yaohong T; Saeed AM; Murillo JC; Komanduri KV; Levy RB; Perez VL
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2348-57. PubMed ID: 25655798
[TBL] [Abstract][Full Text] [Related]
43. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
Avivi I; Stroopinsky D; Rowe JM; Katz T
Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
[TBL] [Abstract][Full Text] [Related]
44. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT.
Karimi MA; Bryson JL; Richman LP; Fesnak AD; Leichner TM; Satake A; Vonderheide RH; Raulet DH; Reshef R; Kambayashi T
Blood; 2015 Jun; 125(23):3655-63. PubMed ID: 25788701
[TBL] [Abstract][Full Text] [Related]
45. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
Asavaroengchai W; Wang H; Wang S; Wang L; Bronson R; Sykes M; Yang YG
Biol Blood Marrow Transplant; 2007 Jan; 13(1):46-55. PubMed ID: 17222752
[TBL] [Abstract][Full Text] [Related]
46. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
[TBL] [Abstract][Full Text] [Related]
47. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
[TBL] [Abstract][Full Text] [Related]
48. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
49. Quantity and Quality Reconstitution of NKG2A
Hu LJ; Zhao XY; Yu XX; Lv M; Han TT; Han W; Huang XJ
Biol Blood Marrow Transplant; 2019 Jan; 25(1):1-11. PubMed ID: 30142416
[TBL] [Abstract][Full Text] [Related]
50. The number of T cell allo-epitopes associates with CD4+ and CD8+ T-cell infiltration in pediatric cutaneous GVHD.
Thus KA; van Halteren AG; de Hond TA; van Dijk MR; Kloos RQ; Lankester AC; Bierings MB; Spierings E
Cell Immunol; 2015 Jun; 295(2):112-7. PubMed ID: 25880102
[TBL] [Abstract][Full Text] [Related]
51. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
52. CD38
Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
[TBL] [Abstract][Full Text] [Related]
53. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
54. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
[TBL] [Abstract][Full Text] [Related]
55. Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.
Moy RH; Huffman AP; Richman LP; Crisalli L; Wang XK; Hoxie JA; Mick R; Emerson SG; Zhang Y; Vonderheide RH; Porter DL; Reshef R
Blood; 2017 Feb; 129(7):906-916. PubMed ID: 28057639
[TBL] [Abstract][Full Text] [Related]
56. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
[TBL] [Abstract][Full Text] [Related]
57. α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease.
Ibrahimova A; Davies SM; Lane A; Jordan MB; Lake K; Litts B; Chaturvedi V; Owsley E; Myers KC; Nelson AS; Mehta PA; Marsh RA; Khandelwal P
Pediatr Blood Cancer; 2021 Aug; 68(8):e28968. PubMed ID: 33861521
[TBL] [Abstract][Full Text] [Related]
58. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
[TBL] [Abstract][Full Text] [Related]
59. Increased splenic human CD4
Geraghty NJ; Belfiore L; Adhikary SR; Alexander SI; Sluyter R; Watson D
Transpl Immunol; 2019 Jun; 54():38-46. PubMed ID: 30743002
[TBL] [Abstract][Full Text] [Related]
60. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
